Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin
Malignant rhabdoid tumour (MRT) is a rare, aggressive paediatric malignancy most commonly diagnosed in those below the age of three. MRTs can arise in soft tissue but are more often associated with the central nervous system or kidney. Unfortunately, the prognosis upon diagnosis with MRT is poor. Gi...
Main Authors: | Rachel Coyle, Maureen J O'Sullivan, Daniela M Zisterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294222000697 |
Similar Items
-
Evaluation of targeting autophagy for the treatment of malignant rhabdoid tumours
by: Patricia Hannon Barroeta, et al.
Published: (2022-01-01) -
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
by: Laurence Dubrez, et al.
Published: (2013-03-01) -
Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy
by: Wai C. Chong, et al.
Published: (2021-10-01) -
Malignant rhabdoid tumor of liver
by: Sandeep Agarwala, et al.
Published: (2014-01-01) -
Neonatal malignant rhabdoid tumor of the neck
by: Gang Wen, et al.
Published: (2023-10-01)